Indications & Uses
Steson is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Apply to the affected area up to four times a day until the condition improves; the frequency of application can then be reduced.
Side Effects
In the unlikely event that signs of hypersensitivity appear, stop applying the product immediately. When Steson is used over large areas of the body, there is a possibility that some patients may absorb enough steroid to cause transient adrenal suppression, even though Steson has a low degree of systemic activity. Local atopic changes could possibly occur where moisture increases the absorption of Steson, but only after prolonged use. There are reports of pigmentation changes and hypertrichosis with topical steroids. Exacerbation of symptoms may occur.
Cautions & Contraindications
Warnings & Precautions
When applied to large areas of skin, to broken skin, or under an occlusive (air‑tight) dressing, enough of this medicine may be absorbed to cause effects throughout the body. Use with care in people with peptic ulcer, osteoporosis, psychoses or severe psychoneuroses. It should not be used indiscriminately for pruritus (itching). Caution is also needed in congestive heart failure (CHF) or hypertension, and in diabetes mellitus, epilepsy, glaucoma, infectious diseases, ocular herpes simplex, chronic renal failure and uraemia. Care is required in active tuberculosis, or tuberculosis that is only doubtfully quiescent. It is not suitable for local treatment of eye disorders. Use carefully in the elderly, and avoid prolonged use on the face.
Contraindications
Clobetasone butyrate preparations should not be used on skin lesions caused by infection with viruses (such as herpes simplex or chicken pox), fungi (such as candidiasis or tinea) or bacteria (such as impetigo), or by anyone with hypersensitivity to the preparations. Although these preparations are generally regarded as safe, even for long-term use in adults, overdosage is possible, and in infants and children this may lead to adrenal suppression. Extreme caution is required when treating dermatoses in such patients, including napkin eruption (as the napkin may act as an occlusive dressing and increase absorption), and treatment should not normally exceed seven days. Appropriate antimicrobial therapy should be used whenever inflammatory lesions that have become infected are treated. If the infection spreads, topical corticosteroid therapy must be withdrawn and antimicrobial agents given systemically. As with all corticosteroids, prolonged application to the face is undesirable. Topical corticosteroids may be hazardous in psoriasis for a number of reasons, including rebound relapses, development of tolerance, and the risk of generalised toxicity due to the impaired barrier function of the skin. If used in psoriasis, careful patient supervision is important. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye, as glaucoma might result.